Wei Yee Chan

8PUBLICATIONS
35CO-AUTHORS
Gene and molecular therapyMedical infection agents (incl. prions)Medical virologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 21, 2025
Venetoclax-based non-intensive combinations for relapsed/refractory acute myeloid leukaemia-Real-world data from a UK-wide programme.

Henry Wood, Jenny O'Nions, Wei Yee Chan

|Jan 19, 2024
Budding yeast as an ideal model for elucidating the role of N6-methyladenosine in regulating gene expression.

Waleed S Albihlal, Wei Yee Chan, Folkert J van Werven

|Aug 30, 2023
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy.

Jad Othman, Ing S Tiong, Jenny O'Nions

|May 10, 2022
Antibody responses to SARS-CoV-2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti-cancer therapies.

Wei Yee Chan, Catherine Zhu, Emilie Sanchez

|Oct 12, 2021
Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial.

Wei Yee Chan, Nicholas Counsell, Ruth de Tute

|Oct 11, 2021
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.

Wei Yee Chan, Lara Howells, William Wilson

Pageof 2

Frequent Collaborators

3 joint publications

Ke Xu

3 joint publications

Kwee L Yong

2 joint publications

Selina J Chavda

2 joint publications

Catherine S Y Lecat